Immunisation, vaccine and travel advice for Afghanistan.


Areas below 2000m, from May until November:

Recommended adult regimen:

Proguanil 200mg daily plus chloroquine base 310mg (2 tablets) or 300mg (30ml of 50mg/5ml syrup) weekly. Begin one week before travel to affected area and continue for four weeks after leaving.

Alternative regimen:

Healthcare professionals only may check with the National Travel Health Network and Centre (NaTHNaC) on 0845 6026712 (9.00-11.45am & 1.00-3.45pm, Mon, Tue, Thu, Fri; 9.00-11.45am, Wed; closed on Bank Holidays).


Travellers should be up to date with routinely recommended vaccinations according to the routine UK immunisation programme.

Vaccination recommended for travellers whose activities put them at increased risk, including those visiting friends and relatives, those in contact with an infected person, young children, long-stay travellers, and those visiting areas of poor sanitation.

Hepatitis A
Vaccination recommended for all previously unvaccinated travellers. Hepatitis A vaccine is well tolerated and affords long-lasting protection.

Hepatitis B
Vaccination recommended for travellers whose activities or medical history put them at increased risk, including those who may have unprotected sex, those who may be exposed to contaminated needles (eg, through injecting drug use or receiving medical or dental care), those who may be exposed to blood or body fluids through their work (eg, health workers), long-stay travellers, those who are participating in contact sports and families adopting children from this country.

All travellers should have completed a polio vaccination course according to the UK schedule. A booster dose of a polio-containing vaccine is recommended for those who have not received a dose within the previous 10 years.

Additional interim advice:

Travellers to settings with extremely poor hygiene (eg, refugee camps) or likely to be in close proximity with cases (eg, healthcare workers), and/or visiting for 6 months or more, are advised to have a booster dose of polio-containing vaccine if they had not received vaccination in the past 12 months.

Travellers who intend to visit Afghanistan for four weeks or more should be aware that proof of vaccination, given four weeks to 12 months before departure from the country (an International Certificate of Vaccination or Prophylaxis [ICVP]), may be required on exit. Failure to produce this documentation may result in vaccination at the point of departure.

Immunosuppressed travellers and their household contacts and pregnant travellers who plan to travel to Afghanistan for one month or more are strongly advised to receive inactivated polio vaccine (IPV) within 1 year before planned departure from Afghanistan and to ensure this is recorded on an ICVP.

Vaccination recommended for travellers whose activities put them at increased risk, including those at risk due to their work (eg, health workers or those working with animals), those travelling to areas where access to post-exposure treatment and medical care is limited, those planning higher risk activities such as running or cycling, and long-stay travellers.

Vaccination recommended for travellers whose activities or medical history put them at increased risk, including aid workers and travellers those going to areas of cholera outbreaks who have limited access to safe water and medical care.

Yellow fever
International Certificate of Vaccination or Prophylaxis (ICVP) required if arriving from a country with a risk of yellow fever transmission.
If a receiving country requires an ICVP as a condition of entry, and the individual should not receive the vaccine on medical grounds, a letter of medical exemption can be considered.

Travellers should have completed a primary vaccination course according to the UK schedule. If travelling to a country where medical facilities may be limited, a booster dose of a tetanus-containing vaccine is recommended if the last dose was more than ten years ago even if five doses of vaccine have been given previously.

Vaccination recommended for travellers at increased risk of developing severe disease and/or of exposure to TB, including unvaccinated children under 16 years of age who are going to live for more than 3 months in this country and unvaccinated, tuberculin skin test negative individuals under 35 years of age at risk because of their work (eg, healthcare workers, prison staff and vets).

Further information

Abbreviated information provided by the National Travel Health Network and Centre (NaTHNaC). Refer to the Afghanistan page on for full details. 

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.